financetom
ZYXI
financetom
/
Healthcare
/
ZYXI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Zynex, Inc.ZYXI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device.

It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products.

In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support.

Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter.

The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring.

It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Latest News >
Biba Apparels files papers for IPO to raise around Rs 1,500 crore
Biba Apparels files papers for IPO to raise around Rs 1,500 crore
Apr 12, 2022
In the past few months, a spate of domestic fashion labels backed by private equity firms has made a beeline for Dalal Street. Sequoia Capital-backed women's bottom-wear brand Go Colours raised Rs 1,014 crore via its IPO and made a stellar debut on the bourses in November, listing at a 90 percent premium to its issue price.
India valuations expensive; inflation may hit US growth too: Credit Suisse
India valuations expensive; inflation may hit US growth too: Credit Suisse
Apr 12, 2022
In an interview with CNBC-TV18, Suresh Tantia, Senior Investment Strategist, Credit Suisse, said that he is cautious on India due to expensive valuations. He also said that there might be a slowdown in growth in Europe due to the Russia-Ukraine war. He believes US may face a similar turmoil too and higher inflation over there could impact growth.
Maruti Suzuki gains after co says fire incident will not affect production ops
Maruti Suzuki gains after co says fire incident will not affect production ops
Apr 12, 2022
Maruti Suzuki share price: After oscillating between losses and gains in early trade on Tuesday, shares of Maruti Suzuki India entered into the positive territory. At 9:30 am, the stock was trading 1.4 percent higher at Rs 7,669.9 on BSE. Today’s gains in the automaker’s stock was after the company said that the fire incident at the company’s R&D centre does not affect the production operations of Maruti Suzuki India.
Delta Corp shares fall 4% after net profit falls 17%; under F&O ban on NSE today
Delta Corp shares fall 4% after net profit falls 17%; under F&O ban on NSE today
Apr 12, 2022
Shares of Delta Corp fell over 4 percent in morning trade on Tuesday after the company reported a 17 percent decline in consolidated net profit for the fourth quarter to Rs 48 crore as compared to Rs 58 crore in the corresponding period of last year. The company's sales rose marginally to Rs 218 crore for the March quarter under review compared to Rs 211 crore in the year-ago period.
Copyright 2023-2026 - www.financetom.com All Rights Reserved